Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light
批准号:
8609764
负责人:
Jonathan F Lovell
金额:
$38.94万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-19 至 2018-08-31
关键词:
Antineoplastic AgentsBiocompatibleBiodistributionBiologicalBiological ProcessBiotinBlood CirculationBlood flowBody TemperatureBuffaloesCaliberDepositionDoxorubicinDrug Delivery SystemsEnvironmentExposure toFiber OpticsHeartHeatingHumanIn VitroIonsLabelLeadLightLiposomesMalignant NeoplasmsMedicalMembraneMethodsNude MicePenetrationPermeabilityPharmaceutical PreparationsPhospholipidsPhysiologicalPorphyrinsProceduresProcessProteinsRecoveryRetrievalSamplingSideSiteSolid NeoplasmSolutionsStimulusSystemTechnologyTemperatureTherapeuticTimeTissuesUniversitiesVesicleXenograft procedurebasechemical reactioncontrolled releaseirradiationmonomernanocarriernanoparticlenanoscalenanovesiclenovelnovel strategiespH gradientpreventpublic health relevanceresearch studyresponsesealtumorunilamellar vesicle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
At present, few synthetic systems can achieve robust, on-demand spatial and temporal control of micro or
nanovesicle permeabilization in biological environments. We propose to build upon proof-of-principle
experiments establishing the feasibility of such a membrane permeabilization system and to apply this
technology towards: 1) triggering drug release in tumors and 2) capturing tumor microvasculature contents via
a remote loading and retrieval approach. Several methods for cargo release driven by external stimuli driven
have been proposed; whereas to our knowledge the concept of remote capture and retrieval of microvessel
contents using triggered permeability in nanovesicles has not yet been explored. So far, essentially all
biocompatible approaches for externally triggered membrane permeabilization from nanocarriers comprise
systems that release their contents when the surrounding temperatures are raised by a few degrees above
body temperature via direct or indirect heating. However, such mechanisms are not amenable to trigger-side
release modulation and the narrow thermal operating window precludes carrier stability at physiological
temperatures. Furthermore, the lack of stability in physiological conditions prevents more demanding
applications of these materials such as triggered release at later time points as well as remote loading and
recovery. Here, we propose a fundamentally new controlled release system based on porphyrin-
phospholipid doped (PoPD) liposomes transiently permeabilized directly by near infrared (NIR) light, a
clinically-applicable stimulus that has negligible actuation in the "off state" and minimal interference with
biological tissues. The ability to open and close nanovesicles in the body with precise spatial and temporal
control could lead to entirely new approaches to treating and understanding cancer. We synthesized a novel
light-absorbing monomer esterified from clinically approved components that gave rise to highly stable
porphyrin bilayer. Remarkably, rapid and complete cargo release was induced upon brief exposure to mild NIR
irradiation using an optimal porphyrin-phospholipid (but not free porphyrin) doping. Unlike previously described
systems, release occurred in the absence of bulk solution photothermal heating or chemical reactions. In
physiological conditions in vitro, NIR irradiation induced a 25,000 fold increase in the release rate of
actively loaded doxorubicin, orders of magnitude greater than previously described triggered release
methods. Induced permeability could be used for both unloading and loading cargo, and could be modulated
by varying porphyrin doping, irradiation intensity and irradiation duration for highly tunable manipulation of
permeabilization. This project has three specific aims. Aim 1: Develop micro and nanovesicles that open and
close on demand in response to NIR light;. Aim 2: Use near infrared light to deliver cancer therapeutics to
tumors; Aim 3: Sample tumor microvasculature contents using a capture and retrieve strategy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis
-
批准号:10598146
-
项目类别:
-
资助金额:$45.87万
-
财政年份:2022
-
负责人:Jonathan F Lovell
-
依托单位:
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis
-
批准号:10441958
-
项目类别:
-
资助金额:$48.09万
-
财政年份:2022
-
负责人:Jonathan F Lovell
-
依托单位:
Light-Triggered Drug Release in Primed Pancreatic Tumors
-
批准号:8562197
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2013
-
负责人:Jonathan F Lovell
-
依托单位:
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light
-
批准号:8737994
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2013
-
负责人:Jonathan F Lovell
-
依托单位:
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light
-
批准号:9135540
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2013
-
负责人:Jonathan F Lovell
-
依托单位:
Light-Triggered Drug Release in Primed Pancreatic Tumors
-
批准号:9130825
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2013
-
负责人:Jonathan F Lovell
-
依托单位:
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light
-
批准号:10190938
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2013
-
负责人:Jonathan F Lovell
-
依托单位:
Light-Triggered Drug Release in Primed Pancreatic Tumors
-
批准号:8717660
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2013
-
负责人:Jonathan F Lovell
-
依托单位:
海外基金